Welcome to the new Tamingthesru
Same great content - new look - improved search
Grand Rounds Recap 5.2.18
This week at UCEM Grand Rounds we had our annual Disaster Day run by the Division of EMS. We discussed our local resources and then participated in a two hour simulated disaster exercise in which a dirty bomb exploded. Dr. Calhoun then closed things out with a discussion on radiation injuries and Hazmat precautions.
Grand Rounds Recap 4.25.18
This week’s Grand Rounds was kicked off with our W. Brian Gibler visiting professor series with Dr. Ali Raja M.D., MBA, MPH, and Vice Chair of Emergency Medicine at Massachusetts General Hospital. He gave us his insights on how to help move our specialty towards evidence based practice, as well as his tips on leadership within the context of academic emergency medicine. This was followed by our monthly Morbidity and Mortality Conference with Dr. Titone. Dr. Shah then gave his R4 Clinical Soap Box on the utility of ultrasound in cardiac arrest, and the conference finished with Dr. Whitford giving his R3 Taming the SRU case follow up.
Rhogam Redux
Hemolytic Disease of the Fetus and Newborn (HDFN) is an alloimmune disease which develops in a fetus when a women’s immune system is sensitized, developing antibodies which cross the placenta and attack fetal RBCs.
While there is a spectrum of the disease, in severe cases the fetus can ultimately develop hydrops fetalis which is often fatal.
As Emergency Physician’s we are classically taught that we can help to prevent HDFN by recognizing sensitizing events in Rh-negative women and subsequently providing RhoGAM. But which patients really need RhoGAM? The evidence seems to be lacking and recommendations are often inconsistent.